These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 3133696)

  • 1. Psychomotor stimulant effects of methylxanthines in squirrel monkeys: relation to adenosine antagonism.
    Spealman RD
    Psychopharmacology (Berl); 1988; 95(1):19-24. PubMed ID: 3133696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the behavioral effects of chlordiazepoxide by methylxanthines and analogs of adenosine in squirrel monkeys.
    Coffin VL; Spealman RD
    J Pharmacol Exp Ther; 1985 Dec; 235(3):724-8. PubMed ID: 2416907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychomotor-stimulant effects of 3-isobutyl-1-methylxanthine: comparison with caffeine and 7-(2-chloroethyl) theophylline.
    Coffin VL; Spealman RD
    Eur J Pharmacol; 1989 Oct; 170(1-2):35-40. PubMed ID: 2482186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respiratory effects of xanthines and adenosine analogs in rhesus monkeys.
    Howell LL; Morse WH; Spealman RD
    J Pharmacol Exp Ther; 1990 Sep; 254(3):786-91. PubMed ID: 2395111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of adenosine analogs alone and in combination with caffeine in the squirrel monkey.
    Katz JL; Prada JA; Goldberg SR
    Pharmacol Biochem Behav; 1988 Feb; 29(2):429-32. PubMed ID: 3362936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of the behavioral effects of L-phenylisopropyladenosine (L-PIA) by caffeine and its metabolites.
    Logan L; Carney JM
    Pharmacol Biochem Behav; 1984 Sep; 21(3):375-9. PubMed ID: 6494209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminative-stimulus effects of adenosine analogs: mediation by adenosine A2 receptors.
    Spealman RD; Coffin VL
    J Pharmacol Exp Ther; 1988 Aug; 246(2):610-8. PubMed ID: 3404449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral interaction of adenosine and methylxanthines on central purinergic systems.
    Coffin VL; Taylor JA; Phillis JW; Altman HJ; Barraco RA
    Neurosci Lett; 1984 Jun; 47(2):91-8. PubMed ID: 6205333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further investigations into adenosine A1 receptor-mediated contraction in rat colonic muscularis mucosae and its augmentation by certain alkylxanthine antagonists.
    Reeves JJ; Jarvis JE; Sheehan MJ; Strong P
    Br J Pharmacol; 1995 Mar; 114(5):999-1004. PubMed ID: 7780657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism of adenosine-induced relaxation by methylxanthines in coronary artery.
    Ramagopal MV; Rash VA; Mustafa SJ
    Arch Int Pharmacodyn Ther; 1988; 295():174-80. PubMed ID: 3245733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition by xanthine derivatives of adenosine receptor-stimulated cyclic adenosine 3',5'-monophosphate accumulation in rat and guinea-pig thymocytes.
    Fredholm BB; Sandberg G
    Br J Pharmacol; 1983 Dec; 80(4):639-44. PubMed ID: 6100843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative effects of CGS 15943, a competitive adenosine receptor antagonist, in monkeys: comparison to methylxanthines.
    Holtzman SG
    J Pharmacol Exp Ther; 1996 May; 277(2):739-46. PubMed ID: 8627553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral effects of A1- and A2-selective adenosine agonists and antagonists: evidence for synergism and antagonism.
    Nikodijević O; Sarges R; Daly JW; Jacobson KA
    J Pharmacol Exp Ther; 1991 Oct; 259(1):286-94. PubMed ID: 1920121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral characterization of caffeine and adenosine agonists during chronic caffeine exposure.
    Newland MC; Brown K
    Behav Pharmacol; 1997 Feb; 8(1):17-30. PubMed ID: 9832997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine A1 and non-A1 receptors: intracellular analysis of the actions of adenosine agonists and antagonists in rat hippocampal neurons.
    Ameri A; Jurna I
    Brain Res; 1991 Apr; 546(1):69-78. PubMed ID: 1855150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postsynaptic dopamine/adenosine interaction: II. Postsynaptic dopamine agonism and adenosine antagonism of methylxanthines in short-term reserpinized mice.
    Ferré S; Herrera-Marschitz M; Grabowska-Andén M; Casas M; Ungerstedt U; Andén NE
    Eur J Pharmacol; 1991 Jan; 192(1):31-7. PubMed ID: 1828237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral and cardiovascular effects of analogs of adenosine in cynomolgus monkeys.
    Coffin VL; Spealman RD
    J Pharmacol Exp Ther; 1987 Apr; 241(1):76-83. PubMed ID: 3572798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory and excitatory effects of adenosine antagonists on spontaneous locomotor activity in mice.
    Florio C; Rosati AM; Traversa U; Vertua R
    Life Sci; 1997; 60(17):1477-86. PubMed ID: 9126868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison between the adenosine receptors mediating adenylate cyclase inhibition and cardiac depression in the guinea pig heart.
    Leung E; Johnston CI; Woodcock EA
    J Cardiovasc Pharmacol; 1986; 8(5):1003-8. PubMed ID: 2429072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological analysis of the interaction between purinoceptor agonists and antagonists in the guinea-pig taenia caecum.
    Prentice DJ; Shankley NP; Black JW
    Br J Pharmacol; 1995 Jun; 115(4):549-56. PubMed ID: 7582471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.